US Pre-Market SEC Filings Roundup — February 03, 2026

04-02-2026

OLD DOMINION FREIGHT LINE, INC. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036791) disclosing Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

04-02-2026

CME Group Inc. filed an 8-K on February 04, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure with no quantitative metrics available for analysis.

04-02-2026

Eli Lilly & Co filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified performance metrics.

04-02-2026

04-02-2026

04-02-2026

04-02-2026

ConnectM Technology Solutions, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. The disclosure appears informational without quantified positive or negative impacts.

04-02-2026

Stanley Black & Decker, Inc. filed an 8-K on February 4, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.

04-02-2026

Ares Capital Corp filed a Form 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. This multi-item filing includes attached financial statements but no specific metrics, changes, or comparisons disclosed in the provided details. No positive or negative performance indicators are available.

• ·AccNo: 0001287750-26-000004
• ·File Size: 521 KB

04-02-2026

Yum China Holdings, Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. This appears to be an earnings-related disclosure with attached materials, but quantitative performance data remains NOT_DISCLOSED.

04-02-2026

Allied Gaming & Entertainment Inc. filed a Form 8-K on February 04, 2026, reporting under Item 5.07 the results of matters submitted to a vote of security holders, Item 7.01 a Regulation FD Disclosure, and Item 9.01 listing financial statements and exhibits. No specific vote outcomes, disclosure details, numerical metrics, or financial impacts are disclosed in the provided filing summary.

04-02-2026

Cooper Companies, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. No specific details on the agreement's nature, parties, dollar value, or financial impacts are disclosed. This is a multi-item filing focused on a material event, but lacks quantitative metrics or comparisons.

04-02-2026

Sky Harbour Group Corp filed an 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction details, financial impacts, or exhibits are disclosed in the provided filing information. This appears to be a multi-item filing with limited transparency on materiality.

04-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary.

04-02-2026

MicroVision, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001493152-26-004952, Size: 204 KB) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides for financial statements and exhibits related to the event. No specific details on transaction parties, value, structure, or impacts are disclosed.

04-02-2026

HANOVER INSURANCE GROUP, INC. filed a Form 8-K on February 04, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were mentioned. Sector details are not specified.

• ·AccNo: 0001193125-26-036103
• ·Filing size: 7 MB

04-02-2026

LAM Research Corp filed an 8-K on February 4, 2026 (AccNo: 0000707549-26-000014), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.

04-02-2026

Triller Group Inc. filed a Form 8-K on February 04, 2026, specifically under Item 4.01 reporting changes in its certifying accountant. No additional details such as the identity of the prior or new accountant, reasons for the change (e.g., resignation, dismissal, disagreements), financial impacts, or strategic context are disclosed in the filing summary. This is a mandatory single-item disclosure with no quantitative metrics provided.

04-02-2026

Launch One Acquisition Corp. filed an 8-K on 2026-02-04 announcing the termination of a material definitive agreement under Item 1.02. Item 9.01 discloses financial statements and exhibits, but no specific details, metrics, or context are provided. No positive developments or offsetting information reported.

04-02-2026

CaliberCos Inc. filed a Form 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with Accession Number 0001627282-26-000002 and file size 413 KB. This is a multi-item voluntary disclosure likely including material non-public information and attached exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

• ·Accession Number: 0001627282-26-000002

04-02-2026

Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.

04-02-2026

Oaktree Specialty Lending Corp filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, with Item 9.01 attaching financial statements and exhibits. No specific revenue, earnings, balance sheet changes, or period-over-period comparisons were disclosed in the provided filing summary. This represents a standard mandatory earnings-related disclosure without quantified metrics.

04-02-2026

News Corp filed a Form 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary provided. This is a multi-item informational filing with no quantitative metrics, transactions, or directional impacts explicitly stated.

04-02-2026

CITY HOLDING CO filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This is a multi-item informational filing with no quantitative metrics or directional impacts provided.

04-02-2026

Keurig Dr Pepper Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial impacts, transactions, or metrics are disclosed in the filing summary. This appears to be a multi-item informational filing with attached exhibits.

04-02-2026

Bunge Global SA filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing details. This is an informational disclosure of financial results with no directional performance indicators available.

04-02-2026

The filer submitted an 8-K on February 4, 2026 (AccNo: 0001213900-26-011634), disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition event, alongside unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No specific details on parties, deal structure, valuation, or financial terms are provided in the filing description. This represents a significant corporate development but lacks quantitative data or strategic rationale for assessment.

04-02-2026

Boston Scientific Corp filed a Form 8-K on February 4, 2026 (AccNo: 0000885725-26-000006), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet effects, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified metrics.

04-02-2026

Cognizant Technology Solutions Corp filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing summary. No positive or negative performance details, period-over-period comparisons, or balance sheet effects are mentioned.

04-02-2026

GE HealthCare Technologies Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided information. This represents a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.

• ·AccNo: 0001932393-26-000006
• ·Filing size: 1 MB
• ·Event Type: Financial Results
• ·Sector: not specified

04-02-2026

Eva Live Inc filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary provided. This is a multi-item filing with no quantitative data or directional impacts mentioned.

04-02-2026

Inspirato Inc filed an 8-K on 2026-02-04 announcing the completion of an acquisition or disposition of assets (Item 2.01) alongside a change in control of the registrant (Item 5.01). However, the filing also discloses termination of a material definitive agreement (Item 1.02), notice of delisting or failure to satisfy a continued listing rule (Item 3.01), and material modifications to rights of security holders (Item 3.03), which may negatively impact liquidity and shareholder value. Additional disclosures include changes in directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD information (Item 7.01).

04-02-2026

BIO-TECHNE Corp filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided information. This is a multi-item filing typical for earnings releases, but detailed financial data and period-over-period comparisons are NOT_DISCLOSED.

04-02-2026

Valuence Merger Corp. I filed an 8-K on February 4, 2026 (AccNo: 0001493152-26-004997) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed. Sector is not specified.

04-02-2026

Cencora, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are provided in the available information.

04-02-2026

Equifax Inc filed an 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.

04-02-2026

Avery Dennison Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned. All quantitative financial metrics and performance details are NOT_DISCLOSED.

04-02-2026

Kennametal Inc. filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005264), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard earnings-related disclosure with exhibits likely containing press release or financial tables, but key metrics are NOT_DISCLOSED.

04-02-2026

Evercore Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure without detailed performance data.

04-02-2026

Vishay Intertechnology Inc filed an 8-K on February 4, 2026 (AccNo: 0000103730-26-000008), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.

04-02-2026

Timken Co filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with all key performance data NOT_DISCLOSED.

04-02-2026

Wabash National Corp filed an 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.

04-02-2026

Uber Technologies, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or financial metrics are disclosed. The filing size is 696 KB with AccNo 0001543151-26-000011.

04-02-2026

Bit Digital, Inc. filed a Form 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosure content, transaction values, financial metrics, or exhibits provided.

04-02-2026

Adient plc filed a Form 8-K on February 4, 2026 (AccNo: 0001670541-26-000022), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned. This is a standard earnings-related disclosure with no directional performance data provided.

04-02-2026

YUM Brands Inc filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This represents a standard multi-item earnings-related disclosure.

04-02-2026

Silicon Laboratories Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing details. This is a standard earnings-related disclosure without detailed performance data.

04-02-2026

Price T Rowe Group Inc filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005273), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results with attached exhibits, but no specific revenue, earnings, margins, or other quantitative metrics are disclosed in the provided filing details. No period-over-period comparisons, guidance, or material changes are mentioned.

04-02-2026

Orion Group Holdings Inc filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), which represents a significant corporate event. However, the filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and unregistered sales of equity securities (Item 3.02), introducing potential debt and dilution risks. Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01) are included, but no specific deal terms or financial metrics are detailed.

04-02-2026

Lear Corp filed a Form 8-K on 2026-02-04 (AccNo: 0000842162-26-000005, size 538 KB) reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard financial results disclosure without directional indicators on performance.

04-02-2026

Johnson Controls International plc filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the filing summary provided. Critical financial details are likely in attached exhibits but not extracted here.

04-02-2026

CDW Corp filed a Form 8-K on February 04, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard earnings-related 8-K with attached exhibits, but detailed results are NOT_DISCLOSED.

04-02-2026

Valvoline Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing summary. This is a multi-item filing typical for quarterly earnings releases.

04-02-2026

New York Times Co filed an 8-K on February 4, 2026 (AccNo: 0000071691-26-000008, Size: 1 MB), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. This is a standard multi-item filing for financial results disclosure. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

04-02-2026

Reynolds Consumer Products Inc. filed an 8-K on 2026-02-04 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information. This is a multi-item earnings-related disclosure with attached exhibits, but quantitative details are NOT_DISCLOSED.

04-02-2026

Haymaker Acquisition Corp. 4 filed an 8-K on 2026-02-04 (AccNo: 0001104659-26-010028, Size: 274 KB) disclosing unregistered sales of equity securities under Item 3.02, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, and financial statements and exhibits under Item 9.01. No quantitative metrics, period-over-period comparisons, deal structure details, parties involved, valuation, synergies, or other transaction specifics are explicitly stated. No positive or negative performance metrics are present.

04-02-2026

IDEX Corp (/DE/) filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.

04-02-2026

Fortive Corp filed an 8-K on February 4, 2026 (AccNo: 0001659166-26-000003, Size: 785 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No quantitative financial metrics, revenue, earnings, guidance, period-over-period comparisons, positive or negative changes, or other specific data are explicitly stated in the filing description. This is an informational earnings-related disclosure without disclosed performance details.

04-02-2026

FLEX LTD. filed a Form 8-K on February 4, 2026 (AccNo: 0000866374-26-000002, Size: 472 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing disclosing financial results, likely including a press release and attachments. No specific revenue, earnings, guidance, comparisons, or other quantitative financial metrics are explicitly stated in the provided filing information.

04-02-2026

Azenta, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified results available.

• ·Filing Accession Number: 0001437749-26-002876
• ·Filing Size: 889 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

04-02-2026

Texas Instruments Inc filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-036727), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the content of the Regulation FD disclosure or the nature of the financial statements/exhibits provided in the filing summary. No quantitative metrics, transactions, or performance data (positive, negative, or flat) were disclosed.

04-02-2026

Performance Food Group Co filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data.

04-02-2026

Verastem, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010036), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary filing typical for quarterly financial results announcements. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed.

04-02-2026

Medalist Diversified REIT, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010034), reporting entry into a material definitive agreement under Item 1.01, with exhibits attached under Item 9.01. No specific details on the agreement terms, parties, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.

04-02-2026

FUELCELL ENERGY INC filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details such as key positions affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.

04-02-2026

04-02-2026

Fox Corp filed an 8-K on 2026-02-04 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard mandatory disclosure for financial results with no detailed metrics available.

04-02-2026

Fusemachines Inc. filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, parties, financial impacts, or metrics are disclosed.

04-02-2026

Freshpet, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

04-02-2026

LCI Industries filed an 8-K on February 4, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information previously shared selectively under Regulation FD, with exhibits attached (file size 700 KB). No financial metrics, transactions, period-over-period changes, or scheduled events are explicitly stated in the filing summary.

04-02-2026

AbbVie Inc. filed an 8-K on 2026-02-04 under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.

04-02-2026

Functional Brands Inc. filed a Form 8-K on February 4, 2026, under Item 3.03 disclosing material modifications to rights of security holders. Item 9.01 lists financial statements and exhibits. No specific details on the modifications, financial impacts, dollar values, or quantitative metrics were provided.

04-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing, but specific details of the other events, transactions, or exhibits are NOT_DISCLOSED in the provided information. No financial metrics, changes, or impacts are mentioned.

04-02-2026

UNITED RENTALS, INC. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

04-02-2026

AMERICAN FINANCIAL GROUP INC filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-036749), disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a standard multi-item filing for financial results with no specific revenue, earnings, or other quantitative metrics disclosed in the provided information. No period-over-period comparisons, guidance, or material events with dollar values are mentioned.

04-02-2026

DT Cloud Star Acquisition Corp filed an 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No merger/acquisition details, quantitative metrics, parties, valuations, or performance data were explicitly stated in the filing summary. No positive, negative, or flat metrics reported.

04-02-2026

Allarity Therapeutics, Inc. filed an 8-K on 2026-02-04 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events or contents of the exhibits are disclosed. This is an informational filing without quantified financial metrics, changes, or directional impacts.

04-02-2026

PAVmed Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of another (Item 1.02), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, share counts, or financial impacts are provided in the filing summary. These events suggest potential restructuring or financing activities, but lack of specifics limits assessment of net positive or negative implications.

04-02-2026

Entera Bio Ltd. filed a Form 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, personnel names, or directional impacts (positive or negative) were specified. This is a multi-item informational filing with no disclosed period-over-period comparisons or flat performance indicators.

04-02-2026

Reservoir Media, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard earnings-related disclosure with no directional performance indicators available.

04-02-2026

Howard Hughes Holdings Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010052), reporting under Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing summary. This multi-item filing is primarily informational with attached exhibits.

04-02-2026

GRI Bio, Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data were disclosed in the provided filing details. The disclosure appears informational without directional performance indicators.

04-02-2026

Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. The filing represents a multi-item disclosure of a potentially strategic transaction but also potential share dilution from equity sales. No specific transaction values, share counts, financial impacts, or strategic details are disclosed.

04-02-2026

Cuentas Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and material modifications to rights of security holders under Item 3.03, alongside Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing lacks specific details on transaction terms, financial impacts, or quantitative metrics. Modifications to shareholder rights may introduce dilution risks, while the new agreement could signal strategic opportunities.

04-02-2026

enVVeno Medical Corp filed an 8-K on February 4, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, quantitative data, period-over-period comparisons, or transaction details were mentioned in the provided filing information. This is a multi-item filing likely related to earnings release or operational updates, but lacks detailed content for deeper analysis.

04-02-2026

Matthews International Corp filed an 8-K on February 4, 2026 (AccNo: 0000063296-26-000011), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing for financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, comparisons, or directional indicators are provided in the filing summary.

04-02-2026

Coherus Oncology, Inc. filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the event, financial impacts, transactions, or quantitative metrics are disclosed in the filing information provided. This appears to be a single-item voluntary disclosure with unknown materiality.

04-02-2026

Twin Disc Inc filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This appears to be a voluntary informational filing with attached exhibits.